Ms. Lamont is a managing partner at private equity firm Oak Investment Partners. She will be an independent director on HCA’s board, increasing the board member count to 14, and she will also serve on HCA’s compensation committee and nominating and corporate governance committee.
With Ms. Lamont’s appointment, HCA also announced two current nominating and corporate governance committee members — Stephen Pagliuca of Bain Capital and Michael Michelson of KKR — will resign from those posts.
More Articles on Hospital Executive Moves:
UHS Appoints Eileen McDonnell to Board of Directors
UHS Board Member Leatrice Ducat Resigns
CEO, CFO of HCA’s Central Group to Retire in 2013
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
